According to Gram Research analysis, a 2026 preprint study in mice found that gut bacteria can convert the omega-3 fat EPA into two new compounds, EP-Phe and EP-Leu. Three bacterial species, including Enterococcus faecalis, produced these compounds in lab tests. The findings suggest the gut microbiome may matter for omega-3 supplements, though effects in people remain unknown.
According to research reviewed by Gram, a 2026 preprint study in mice found that gut bacteria can change an omega-3 fat called EPA into new molecules. The team found that the bacteria attach EPA to two amino acids, the building blocks of protein, creating compounds called EP-Phe and EP-Leu. Lab tests on stool samples confirmed that gut microbes make these compounds. The researchers also tested many bacteria common in infant guts and identified three species that produced them. The findings suggest that the bacteria living in our digestive systems may play a role in how omega-3s are processed. Because this work has not yet been peer reviewed and was done mostly in mice and lab dishes, its meaning for people is still unclear. Researchers say the gut microbiome may be worth considering when designing future omega-3 supplements.
Key Statistics
A 2026 preprint study in mice found that gut bacteria converted the omega-3 fat EPA into two new compounds, called EP-Phe and EP-Leu.
A 2026 laboratory study identified three infant gut bacteria species, Enterococcus faecalis, Bacteroides thetaiotaomicron, and Clostridium bifermentans, as producers of these omega-3 derived compounds.
The 2026 bioRxiv preprint showed that gut microbes produce EP-Phe and EP-Leu in stool samples grown in lab dishes, confirming a direct microbial role in omega-3 processing.
The Quick Take
- What they studied: The researchers wanted to know whether gut bacteria interact with omega-3 fats from the diet, and whether that interaction creates new compounds that could affect health.
- Who participated: The main experiments used laboratory mice, along with stool samples grown in lab dishes and a collection of bacteria commonly found in infant guts. The exact number of participants was not specified in the summary.
- Key finding: Gut bacteria converted the omega-3 fat EPA into two new compounds, EP-Phe and EP-Leu. Three bacterial species, Enterococcus faecalis, Bacteroides thetaiotaomicron, and Clostridium bifermentans, were identified as producers of these compounds in lab tests.
- What it means for you: This is early laboratory work, so it does not show that omega-3 supplements behave differently in people. It does suggest that gut bacteria may influence what omega-3 fats do in the body, which could matter for future supplement design. Do not change your supplements based on this study alone.
The Research Details
The researchers attached a small chemical tag to EPA, an omega-3 fat found in fish oil, so they could track it through the body. This tagged fat was given to mice, and the team then examined the ileum, the final section of the small intestine, to see which microbes came into contact with it. They used a method called flow cytometry to count and sort cells that had picked up the tagged fat.
Next, the researchers used a technique called comparative metabolomics, which compares the chemical products found in samples with and without the tagged fat. This approach helped them spot new compounds made from EPA, including EP-Phe and EP-Leu. To confirm that gut bacteria were responsible, they grew stool samples in lab dishes, a setup known as ex vivo culture, and measured these compounds directly.
Finally, the team tested a range of bacteria commonly found in infant guts. They checked which species interacted with EPA and which could produce EP-Phe or EP-Leu. This step narrowed the search to three specific species.
Tagging the fat allowed the team to follow it step by step, which is much more precise than simply measuring the fat before and after eating. Testing both whole animals and isolated bacteria in lab dishes helps show that the bacteria themselves, and not only the host’s body, are responsible for making the new compounds.
This study is a preprint, which means it has been shared publicly before formal review by independent experts. Preprints can be valuable for sharing early results, but their conclusions may change after peer review. The work relies heavily on mice and lab-grown bacteria, so results may not transfer directly to humans. The sample size was not clearly reported, which makes it harder to judge how strong the evidence is.
What the Results Show
The main result is that gut bacteria can take EPA, an omega-3 fat, and attach it to amino acids. This produced two new compounds, EP-Phe and EP-Leu, which the researchers found in the mouse intestine. Amino acids are the small units that make up proteins, so these compounds are a combination of a fat and a protein building block.
When the team grew stool samples in lab dishes, they found that the bacteria themselves were making EP-Phe and EP-Leu. This supports the idea that the gut microbiome, the community of microbes living in the digestive tract, plays an active role in processing dietary fats.
Of the many infant gut bacteria tested, three species stood out as capable producers of these compounds: Enterococcus faecalis, Bacteroides thetaiotaomicron, and Clostridium bifermentans. Each one showed clear interaction with EPA in lab tests. The researchers say this points to specific microbes that may be involved in the process.
The researchers note that omega-3 fats are important for brain development and immune function in infants. Showing that gut microbes help transform these fats adds a new layer to how the body uses them. The authors suggest this may matter when designing supplements for infants, although they did not test any supplement or measure health outcomes directly.
Scientists have long known that omega-3 fats support brain and immune health, and that gut microbes can break down many kinds of food components. This study adds to a growing body of work showing that gut bacteria also help create new signaling compounds from dietary fats. The idea that bacteria attach fats to amino acids to make new molecules is less common in the existing literature, so this work offers a fresh direction for research.
The study was done mainly in mice and in lab-grown bacteria, so it is not yet clear whether the same process happens in people. The paper is a preprint and has not gone through formal peer review. The number of participants was not clearly reported, and the study does not show whether EP-Phe or EP-Leu have any effect on health. Future research will need to test whether these compounds matter in living humans.
The Bottom Line
Based on current evidence, the main takeaway is that gut bacteria may play a role in how omega-3 fats are processed, which is a promising but early finding (low confidence for practical use). People should continue to follow established guidance on eating fish or taking omega-3 supplements as recommended by their healthcare provider. Confidence that these specific compounds affect health in people is currently low.
Researchers studying nutrition, infant health, and the gut microbiome will find this work especially useful. Parents, infant formula designers, and supplement makers may also find it interesting for future planning. Most people do not need to change their diet based on this single early study.
Lab findings like these usually take years to reach human studies, and often longer to influence guidelines or products. Anyone hoping for practical changes should expect a wait of several years at minimum while researchers test whether the findings hold up in people.
Frequently Asked Questions
Can gut bacteria change omega-3 fats into new compounds?
A 2026 preprint study in mice found that gut bacteria can attach the omega-3 fat EPA to amino acids, creating two new compounds called EP-Phe and EP-Leu. The work was done in mice and lab cultures, so human effects are not yet confirmed.
Which gut bacteria help make omega-3 derived compounds?
Researchers identified three infant gut bacteria species as capable producers of EP-Phe or EP-Leu: Enterococcus faecalis, Bacteroides thetaiotaomicron, and Clostridium bifermentans. These results came from lab tests on bacteria grown in dishes.
Does the gut microbiome affect how omega-3 supplements work?
The researchers suggest the gut microbiome may be an important factor in designing omega-3 supplements. The study did not test supplements or measure health outcomes, so this idea remains a hypothesis that needs testing in people.
Should I change my omega-3 intake based on this new study?
This early preprint does not provide clear guidance for changing omega-3 intake. Continue following your healthcare provider’s advice on fish or supplements, since the findings come from mice and lab cultures that have not yet been confirmed in humans.
Want to Apply This Research?
- Log your daily omega-3 intake in grams, including food sources such as fish servings per week and any supplement doses. Track this alongside a simple gut comfort score from 1 to 5 each day so you can see patterns over time.
- Encourage users to eat omega-3-rich foods, such as salmon, sardines, or walnuts, at least twice a week, and to log each serving. Include a reminder to pair these meals with high-fiber foods, since fiber supports a diverse gut microbiome.
- Review omega-3 intake and gut comfort trends every month. Over several months, users can spot whether consistent intake aligns with changes in digestion or energy. Encourage users to share these logs with a healthcare provider before making significant changes to supplements.
This article summarizes a preprint study that has not yet been peer reviewed and was conducted mainly in mice and laboratory cultures. Its findings do not show how omega-3 fats or related compounds affect human health. This content is for general information only and is not medical advice. Consult a qualified healthcare provider before making changes to your diet, supplements, or infant feeding, especially for infants or people with health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.